Immunoturbidimetric measurement of low concentrations of apolipoprotein B in Iipaemic samples
There have been several reports that lipaemia interferes with the determination of apolipoprotein B (apo B) by immunoturbidimetry.l-" We have investigated this phenomenon in very low density lipoprotein (VLDL) fractions relatively rich in triacylglycerol (TAG) and low in apo B. Following an overnight fast, the TAG:apo B ratio (mole:mole) in plasma is around 1000, compared with a ratio of above 20000 in VLDL!. 3 Therefore methods set up for measuring apo B in plasma are likely to require alterations to resolve the problems caused by lipaemia if they are to be used on samples with extremely high TAG: apo B ratios. We were particularly interested in the composition of VLDL subfractions isolated from human plasma in the post-prandial period," when the lipaemia of samples can be particularly marked and the levels of apo B in the VLDL subfractions can be as low as 0'5 mg/dL. We report studies on this problem and propose a method to overcome it.
All reagents, unless stated otherwise, were AnalaR grade and were obtained from Merck Chemicals Ltd (poole, UK). Phosphate-buffered saline (PBS): 1· 97 giL potassium dihydrogen orthophosphate, 9'47 giL disodium hydrogen orthophosphate, 9 giL sodium chloride, and 1 g/L sodium azide, pH 7' 4. Buffered polyethylene glycol (PEG)/Tween: 5 g or 7· 5 g (see below) PEG 6000 (Biochemical grade) and 200 ILL Tween 20 (Koch-Light Laboratories, Colnbrook, UK) in 100 mL PBS. Antiserum and calibration serum were from Boehringer Mannheim UK Ltd (Lewes, UK). The lyophilized calibration serum, based on human serum, was reconstituted in distilled water and diluted with PBS to obtain four working calibrators (at concentrations ranging from -O·6 to 9· 6 mg/dL apo B.) The method was run on an Instrumentation Laboratory Multistat III Microcentrifugal Analyzer [IL (UK) Ltd, Warrington, UK].
Initially apo B was measured using a method based on that described by Mount et al:" The reagent consisted of buffered PEG/Tween (5OJo PEG) containing 3 mL antiserum/l 00 mL. The loader settings were: sample volume 20 ILL (+ 10 ILL distilled water) and 180 ILL reagent (+ 10 ILL distilled water). The reference cuvette contained water. The reaction was run for 9 min at 37°C, and the absorbance measured at 340 nm. However, on inspection of the reaction profile of some samples, the absorbance was seen to show an initial decrease followed by an increase. Such behaviour would result in a falsely low change in absorbance being calculated for the reaction (taken as the change in absorbance from time zero). The initial decrease in absorbance was thought to be caused by the detergent in the reagent 'clearing' the turbidity from the lipaemic samples.
To investigate this, the sample was preincubated with buffered PEG/Tween 20 (7' 5% PEG), but no antiserum. To increase the sensitivity of the assay, the reaction volumes were changed to raise the concentration of apo B in the cuvette: sample volume 60 ILL (+ 10 ILL distilled water), reagent volume 135 ILL ( + 10 ILL distilled water), and the concentration of PEG in the reagent was raised from 5% to 7· 5% (giving a final PEG concentration of 4'7% in the cuvette). The absorbance was monitored over the incubation period of 11 min at 37°C, and showed an initial, rapid drop in absorbance. The reaction was then started by the addition of 5 ILL antiserum and the absorbance followed for 9 min. The resultant reaction profiles showed almost immediate increases in the absorbance (Fig. 1) . The initial decrease in absorbance in the absence of a pre-incubation step could cause an underestimation of apo B by about 15%. However, in highly TAG-rich samples, even the pre-incubation was not enough to remove the interference caused by clearance of the lipaemia. To reduce the turbidity in the cuvette. the sample volume was lowered again, A sample volume of 30 iLL (+ 10 iLL distilled water) was used. with 165 iLL (+ 10 iLL distilled water) of the buffered PEG (7' 5070 )/Tween (giving a final PEG concentration of 5' 7% in the cuvette). Other conditions were as described above. After analysis of samples with a range of TAG concentrations. it became apparent that the TAG concentration was of critical importance in the estimation of apo B. TAG concentrations above about I· 0 mmol/L (resulting in starting absorbances of 40 milliabsorbance units or greater). were too high to allow accurate determination of apo B. The high turbidity of these samples masked the relatively small absorbance changes, resulting in underestimation of apo B by as much as 75% in very lipaemic samples. By diluting these samples in PBS, the turbidity was reduced, and it was found that once the TAG concentration had been reduced to below about I' 0 mmol/L (giving a starting absorbance of below 40 mAbs units). different dilutions of the same sample gave the same result for apo B. The effect of the TAG concentration on the accuracy of the apo B measurement is demonstrated in Fig. 2 .
The precision of the assay was assessed by including in all runs the quality control serum The analysis of lipid components of serum is complicated by the fact that they exist in a hydrophobic environment. which must be solubilized with detergents before measurement. S We have shown that this clearing process produces turbidity changes which, in lipaemic samples, will obscure the immunoturbidimetric measurement of apo B. This problem can be overcome by including a pre-incubation step without the antiserum, as has been suggested in the immunoturbidimetric assay of low concentrations of urinary albumin.P Even under these conditions it is important that the sample is diluted such that the TAG concentration is less than 1·0 mmol/L and the absorbance prior to the addition of the antiserum is below about 40 mAbs units. 
